Navigation Links
Soligenix Announces Results From Its Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
Date:2/10/2012

ear to be consistent with the potential for SGX201 having efficacy for this disorder for which there is currently no available therapy."

"Radiation enteritis is a serious complication for colorectal cancer patients receiving radiation therapy that impacts their quality of life and can require treatment modification," stated William Small, Jr., MD, FACRO, FACR, FASTRO Professor and Vice Chairman, Department of Radiation Oncology, Associate Medical Director, Robert H. Lurie Comprehensive Cancer Center of Northwestern University Feinberg School of Medicine, and a Principal Investigator for the Phase 1/2 clinical study. "Based on oral BDP's proven pharmacology in treating severe gastrointestinal inflammation, SGX201 represents a potential prophylactic option that would enable physicians/patients to maintain planned treatment regimens to battle the underlying malignancy. I find these exploratory data encouraging and I look forward to continuing to work with Soligenix on the continued development of SGX201 in this area of great unmet medical need."

About Acute Radiation Enteritis

Acute radiation enteritis is caused by radiation-induced death of cells in the lining of the bowel. As bowel cells die and are not replaced, gastrointestinal toxicity develops due to an inflammatory response to dead cells and bacteria, with diarrhea, nausea, vomiting and pain prominent symptoms. The addition of chemotherapy may exacerbate the intestinal symptoms and itself cause significant toxicity. This treatment-related enteritis can result in delay or interruption of the cancer treatment. There are over 100,000 patients annually in the United States who receive abdominal or pelvic external beam radiation treatment for cancer, and these patients are at risk of developing radiation enteritis.

About SGX201

SGX201 is a time-release, oral formulation of BDP, a highly potent, topically active corticosteroid that has a local effect on inflamed
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
8. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
9. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
10. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
11. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015 ANSYS (NASDAQ: ... largest independent manufacturer of diesel engines and global power ... it with broad access to the ANSYS ® ... continue to solve some of the industry,s most challenging ... the most innovative products on the market. ...
(Date:2/26/2015)... Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and Dental sectors of healthcare, announced today its record ... December 31, 2014. Full Year and ... Year 2014 revenue of $118.2 million doubles 2013 revenue ...
(Date:2/26/2015)...  PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: ... its annual meeting of stockholders on Thursday, May 28, 2015, ... on April 2, 2015. The meeting will take place at ... . About PDL BioPharma PDL manages a ... et al. patents, license agreements with various biotechnology and pharmaceutical ...
Breaking Medicine Technology:Cummins Standardizes On ANSYS Engineering Simulation Software 2Cummins Standardizes On ANSYS Engineering Simulation Software 3MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 2MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 3MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 4MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 5MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 6MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 7MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 8MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 9MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 10MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 11MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 12MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 13MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 14MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 15MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 16MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 17MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit 18PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2015 2
... Inc. (NASDAQ: VVUS ) today announced that ... review the company,s new drug application (NDA) for its investigational ... The target date for the FDA to complete its review ... announced results from the pivotal phase 3 trials, patients treated ...
... 2011 Kimberly-Clark Health Care (KCHC) announced today ... on synthetic exam gloves due to unprecedented demand ... butadiene and acrylonitrile.   "Despite aggressive ... along with inflationary pressures have been beyond expectations," ...
Cached Medicine Technology:VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction 2VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction 3
(Date:2/26/2015)... When Cosmetic Town launched in 2012, ... included, what will soon be, the cornerstone of work ... plethora of insight that will be accessible to the ... Team has maintained during its existence. Users have more ... treatments by visiting the Cosmetic Town Journal’s doctor’s page. ...
(Date:2/26/2015)... 26, 2015 Imagine a day without access ... proper baths and there was no one to help. For ... was today. In 2015, more than 2.5 billion people will ... , A new initiative led by Nevada’s Desert ... numbers, focusing specifically on women – who often bear the ...
(Date:2/26/2015)... Wound Care Advantage (WCA), ... its executive team by adding three key members possessing ... same time two WCA team members were promoted to ... was founded in 2002 and is one of the ... WCA team believes that providing outstanding patient care is ...
(Date:2/26/2015)... 2015 SpendWell Health, an online ... to its first customer today, opening its doors ... dependents. , SpendWell delivers the next generation ... real-time price transparency with e-commerce. SpendWell’s unique platform ... health care services and allows shoppers to buy ...
(Date:2/26/2015)... 2015 Catalent Pharma Solutions, ... technologies and development solutions for drugs, biologics ... several expanded capabilities within its European Clinical ... implemented in response to increased customer demand ... of highly-potent or temperature-sensitive investigational medical products ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town has now Recreated Itself by Adding New Features 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 2Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 3
... ... Peck reports in his article, The Great Medical Myth, that U.S. Vital ... Medical Establishment misleads the public by hiding: iatrogenic induced deaths, Medicine,s inability ... cures. Medicine has well served society over millennia in easing pain and ...
... ... of custom telecommunications systems for businesses, announces the addition of surveillance ... the New York State Department of State, Select Telecom can now ... Select Telecom, stated that "Our clients have started requesting surveillance system ...
... , , VIENNA, Austria, July ... extraordinary achievements in advancing Alzheimer,s research at its 2009 International ... top papers on neuroimaging were also recognized. , ... , "We are beginning to ...
... July 13, 2009 The Alzheimer,s Association recognized four ... at its 2009 International Conference on Alzheimer,s Disease (ICAD ... were also recognized. "We are beginning to ... the last two decades, including a robust pipeline of ...
... , , VIENNA, Austria, ... and their trusting, personal relationships with local dementia support service ... to new research reported today at the Alzheimer,s Association 2009 ... , , (Logo: ...
... DHA, either in terms of prevention or treatment ... that looked at whether the omega-3 fatty acid DHA ... results. , The studies were done because of "a ... to cognitive function," explained Bill Thies, chief medical and ...
Cached Medicine News:Health News:Scientist Presents Data Countering Medicine's Claim of Increasing Life Span In Midst Of Debate Over Medical Insurance 2Health News:Scientist Presents Data Countering Medicine's Claim of Increasing Life Span In Midst Of Debate Over Medical Insurance 3Health News:Scientist Presents Data Countering Medicine's Claim of Increasing Life Span In Midst Of Debate Over Medical Insurance 4Health News:Select Telecom Adds Surveillance System Installation and Maintenance Services, Receives New York State License 2Health News:Six Scientists Receive Awards for Contributions to Alzheimer's Disease Research 2Health News:Six Scientists Receive Awards for Contributions to Alzheimer's Disease Research 3Health News:Six Scientists Receive Awards for Contributions to Alzheimer's Disease Research 4Health News:6 scientists receive awards for contributions to Alzheimer's disease research 2Health News:6 scientists receive awards for contributions to Alzheimer's disease research 3Health News:Doctors Talk Frankly About What Encourages and Impedes Early Diagnosis of Alzheimer's 2Health News:Doctors Talk Frankly About What Encourages and Impedes Early Diagnosis of Alzheimer's 3Health News:Doctors Talk Frankly About What Encourages and Impedes Early Diagnosis of Alzheimer's 4Health News:Doctors Talk Frankly About What Encourages and Impedes Early Diagnosis of Alzheimer's 5Health News:Omega-3 Fatty Acid Falls Short in Alzheimer's Trials 2Health News:Omega-3 Fatty Acid Falls Short in Alzheimer's Trials 3
... AirSep's LifeStyle Portable Oxygen Concentrator is the ... less than 10 lbs (4.5 kg), this ... working, and highly active oxygen patient., ... combining the technologies of both an oxygen ...
... up to 10 LPM of oxygen reducing the ... The M10 is engineered to reduce the cost ... has fewer parts than any other concentrator on ... help you to reduce expenditure on accessories and ...
... Hudson RCI oxygen conserving ... "split prong" nose design ... tubes with standard connectors. ... utmost control and comfort ...
Proven and Efficient Stand-Alone Device. Offers a choice between alternate breath and every breath delivery. This model provides every breath delivery....
Medicine Products: